

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.07274984 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.07274984 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 5.72007534 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.72007534 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.27633581 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.91424523 |
| 7 | aldehyde catabolic process (GO:0046185) | 4.86930745 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 4.63019678 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 4.63019678 |
| 10 | tryptophan catabolic process (GO:0006569) | 4.63019678 |
| 11 | bile acid biosynthetic process (GO:0006699) | 4.55035924 |
| 12 | tryptophan metabolic process (GO:0006568) | 4.38440429 |
| 13 | glyoxylate metabolic process (GO:0046487) | 4.34616456 |
| 14 | high-density lipoprotein particle remodeling (GO:0034375) | 4.14743311 |
| 15 | kynurenine metabolic process (GO:0070189) | 4.11930738 |
| 16 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.11700059 |
| 17 | cysteine metabolic process (GO:0006534) | 4.01291487 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 3.89646166 |
| 19 | bile acid metabolic process (GO:0008206) | 3.86512580 |
| 20 | cellular ketone body metabolic process (GO:0046950) | 3.86144173 |
| 21 | cellular biogenic amine catabolic process (GO:0042402) | 3.85578941 |
| 22 | amine catabolic process (GO:0009310) | 3.85578941 |
| 23 | tyrosine metabolic process (GO:0006570) | 3.85411759 |
| 24 | aromatic amino acid family metabolic process (GO:0009072) | 3.82959220 |
| 25 | coenzyme catabolic process (GO:0009109) | 3.81169936 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 3.80870997 |
| 27 | uronic acid metabolic process (GO:0006063) | 3.79466411 |
| 28 | glucuronate metabolic process (GO:0019585) | 3.79466411 |
| 29 | regulation of cholesterol esterification (GO:0010872) | 3.77834744 |
| 30 | regulation of triglyceride catabolic process (GO:0010896) | 3.74893226 |
| 31 | fatty acid elongation (GO:0030497) | 3.74576054 |
| 32 | reverse cholesterol transport (GO:0043691) | 3.73785172 |
| 33 | cellular glucuronidation (GO:0052695) | 3.72294305 |
| 34 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.71531389 |
| 35 | protein carboxylation (GO:0018214) | 3.71531389 |
| 36 | plasma lipoprotein particle remodeling (GO:0034369) | 3.69052157 |
| 37 | protein-lipid complex remodeling (GO:0034368) | 3.69052157 |
| 38 | macromolecular complex remodeling (GO:0034367) | 3.69052157 |
| 39 | urea cycle (GO:0000050) | 3.67072700 |
| 40 | urea metabolic process (GO:0019627) | 3.67072700 |
| 41 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.65159001 |
| 42 | complement activation, alternative pathway (GO:0006957) | 3.62728744 |
| 43 | regulation of fibrinolysis (GO:0051917) | 3.61924351 |
| 44 | acylglycerol homeostasis (GO:0055090) | 3.56916689 |
| 45 | triglyceride homeostasis (GO:0070328) | 3.56916689 |
| 46 | phospholipid efflux (GO:0033700) | 3.56140908 |
| 47 | respiratory electron transport chain (GO:0022904) | 3.54531395 |
| 48 | cofactor catabolic process (GO:0051187) | 3.50193110 |
| 49 | indolalkylamine metabolic process (GO:0006586) | 3.49139276 |
| 50 | nitrogen cycle metabolic process (GO:0071941) | 3.48968596 |
| 51 | plasma lipoprotein particle clearance (GO:0034381) | 3.47364322 |
| 52 | regulation of protein activation cascade (GO:2000257) | 3.46018941 |
| 53 | electron transport chain (GO:0022900) | 3.45301228 |
| 54 | very long-chain fatty acid metabolic process (GO:0000038) | 3.45133857 |
| 55 | negative regulation of fibrinolysis (GO:0051918) | 3.45034252 |
| 56 | proteasome assembly (GO:0043248) | 3.41073790 |
| 57 | cullin deneddylation (GO:0010388) | 3.40161286 |
| 58 | cholesterol efflux (GO:0033344) | 3.38562231 |
| 59 | alpha-amino acid catabolic process (GO:1901606) | 3.34600580 |
| 60 | ketone body metabolic process (GO:1902224) | 3.34599655 |
| 61 | homocysteine metabolic process (GO:0050667) | 3.33364323 |
| 62 | ATP synthesis coupled proton transport (GO:0015986) | 3.31565945 |
| 63 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.31565945 |
| 64 | short-chain fatty acid metabolic process (GO:0046459) | 3.24216164 |
| 65 | bile acid and bile salt transport (GO:0015721) | 3.23854064 |
| 66 | low-density lipoprotein particle remodeling (GO:0034374) | 3.21491816 |
| 67 | benzene-containing compound metabolic process (GO:0042537) | 3.21435807 |
| 68 | regulation of complement activation (GO:0030449) | 3.21259105 |
| 69 | NAD biosynthetic process (GO:0009435) | 3.20962225 |
| 70 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.18959136 |
| 71 | amino-acid betaine metabolic process (GO:0006577) | 3.15779885 |
| 72 | cellular amino acid catabolic process (GO:0009063) | 3.15306734 |
| 73 | regulation of mitochondrial translation (GO:0070129) | 3.12161869 |
| 74 | regulation of cell communication by electrical coupling (GO:0010649) | 3.10765742 |
| 75 | opsonization (GO:0008228) | 3.08635111 |
| 76 | glutamate metabolic process (GO:0006536) | 3.07380342 |
| 77 | monocarboxylic acid catabolic process (GO:0072329) | 3.06517042 |
| 78 | negative regulation of lipase activity (GO:0060192) | 3.05732529 |
| 79 | protein complex biogenesis (GO:0070271) | 3.05278622 |
| 80 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.05111467 |
| 81 | acetyl-CoA metabolic process (GO:0006084) | 3.04104670 |
| 82 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.00802440 |
| 83 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.00802440 |
| 84 | drug catabolic process (GO:0042737) | 3.00088547 |
| 85 | carboxylic acid catabolic process (GO:0046395) | 2.99324345 |
| 86 | organic acid catabolic process (GO:0016054) | 2.99324345 |
| 87 | protein deneddylation (GO:0000338) | 2.98344586 |
| 88 | fatty acid catabolic process (GO:0009062) | 2.97889929 |
| 89 | response to nitrosative stress (GO:0051409) | 2.97412411 |
| 90 | serine family amino acid catabolic process (GO:0009071) | 2.97154384 |
| 91 | tricarboxylic acid cycle (GO:0006099) | 2.96793641 |
| 92 | cellular modified amino acid catabolic process (GO:0042219) | 2.93791475 |
| 93 | fatty acid beta-oxidation (GO:0006635) | 2.93772011 |
| 94 | lysine catabolic process (GO:0006554) | 2.93072323 |
| 95 | lysine metabolic process (GO:0006553) | 2.93072323 |
| 96 | fatty acid oxidation (GO:0019395) | 2.92621331 |
| 97 | ethanol oxidation (GO:0006069) | 2.92531660 |
| 98 | chaperone-mediated protein transport (GO:0072321) | 2.92044567 |
| 99 | negative regulation of sterol transport (GO:0032372) | 2.91705269 |
| 100 | negative regulation of cholesterol transport (GO:0032375) | 2.91705269 |
| 101 | thioester metabolic process (GO:0035383) | 2.91066928 |
| 102 | acyl-CoA metabolic process (GO:0006637) | 2.91066928 |
| 103 | fibrinolysis (GO:0042730) | 2.90348168 |
| 104 | imidazole-containing compound metabolic process (GO:0052803) | 2.90288429 |
| 105 | lipid oxidation (GO:0034440) | 2.90275342 |
| 106 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.88203412 |
| 107 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.88203412 |
| 108 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.86813626 |
| 109 | flavonoid metabolic process (GO:0009812) | 2.86422542 |
| 110 | positive regulation of lipid catabolic process (GO:0050996) | 2.84161332 |
| 111 | arginine metabolic process (GO:0006525) | 2.83910921 |
| 112 | ethanol metabolic process (GO:0006067) | 2.83221384 |
| 113 | positive regulation of actin filament depolymerization (GO:0030836) | 2.82750804 |
| 114 | regulation of bile acid biosynthetic process (GO:0070857) | 2.82567486 |
| 115 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.82530755 |
| 116 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.80878271 |
| 117 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.80790955 |
| 118 | NADH dehydrogenase complex assembly (GO:0010257) | 2.80790955 |
| 119 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.80790955 |
| 120 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.80516752 |
| 121 | branched-chain amino acid catabolic process (GO:0009083) | 2.75516813 |
| 122 | heart contraction (GO:0060047) | 2.74579720 |
| 123 | heart process (GO:0003015) | 2.74579720 |
| 124 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.71460282 |
| 125 | cellular potassium ion homeostasis (GO:0030007) | 2.67057344 |
| 126 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.66376641 |
| 127 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.62393463 |
| 128 | protein maturation by protein folding (GO:0022417) | 2.61687034 |
| 129 | glutamate secretion (GO:0014047) | 2.55729859 |
| 130 | establishment of integrated proviral latency (GO:0075713) | 2.53889068 |
| 131 | detection of calcium ion (GO:0005513) | 2.48417233 |
| 132 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.47023693 |
| 133 | regulation of relaxation of muscle (GO:1901077) | 2.45155214 |
| 134 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.44590171 |
| 135 | rRNA modification (GO:0000154) | 2.43757816 |
| 136 | oxidative phosphorylation (GO:0006119) | 2.42352379 |
| 137 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.40888908 |
| 138 | respiratory chain complex IV assembly (GO:0008535) | 2.40167187 |
| 139 | actin-myosin filament sliding (GO:0033275) | 2.37537269 |
| 140 | muscle filament sliding (GO:0030049) | 2.37537269 |
| 141 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.33952343 |
| 142 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.33328968 |
| 143 | lipid particle organization (GO:0034389) | 2.31499084 |
| 144 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.28900739 |
| 145 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.26866412 |
| 146 | regulation of oxidative phosphorylation (GO:0002082) | 2.26091458 |
| 147 | regulation of cofactor metabolic process (GO:0051193) | 2.24146822 |
| 148 | regulation of coenzyme metabolic process (GO:0051196) | 2.24146822 |
| 149 | relaxation of smooth muscle (GO:0044557) | 2.22122194 |
| 150 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.21469871 |
| 151 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.21325483 |
| 152 | response to redox state (GO:0051775) | 2.21215967 |
| 153 | L-methionine salvage (GO:0071267) | 2.20827425 |
| 154 | L-methionine biosynthetic process (GO:0071265) | 2.20827425 |
| 155 | amino acid salvage (GO:0043102) | 2.20827425 |
| 156 | regulation of hexokinase activity (GO:1903299) | 2.20732755 |
| 157 | regulation of glucokinase activity (GO:0033131) | 2.20732755 |
| 158 | rRNA methylation (GO:0031167) | 2.20347969 |
| 159 | regulation of actin filament-based movement (GO:1903115) | 2.19790535 |
| 160 | protein heterotetramerization (GO:0051290) | 2.18886432 |
| 161 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.18582513 |
| 162 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.18103140 |
| 163 | protein targeting to mitochondrion (GO:0006626) | 2.16847050 |
| 164 | intracellular protein transmembrane import (GO:0044743) | 2.16269153 |
| 165 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.15117073 |
| 166 | protein neddylation (GO:0045116) | 2.15111885 |
| 167 | actin-mediated cell contraction (GO:0070252) | 2.14287683 |
| 168 | synaptic vesicle maturation (GO:0016188) | 2.13349147 |
| 169 | hydrogen ion transmembrane transport (GO:1902600) | 2.12418380 |
| 170 | muscle cell cellular homeostasis (GO:0046716) | 2.11962304 |
| 171 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.11343573 |
| 172 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.11167616 |
| 173 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.11167616 |
| 174 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.10912681 |
| 175 | ATP biosynthetic process (GO:0006754) | 2.10238076 |
| 176 | protein localization to mitochondrion (GO:0070585) | 2.09622242 |
| 177 | regulation of sulfur metabolic process (GO:0042762) | 2.05907838 |
| 178 | ribosome assembly (GO:0042255) | 2.05701355 |
| 179 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.05383311 |
| 180 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.03898439 |
| 181 | negative regulation of ligase activity (GO:0051352) | 2.03898439 |
| 182 | lactate metabolic process (GO:0006089) | 2.03686081 |
| 183 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.03161781 |
| 184 | establishment of protein localization to mitochondrion (GO:0072655) | 2.02748857 |
| 185 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.02693238 |
| 186 | vascular smooth muscle contraction (GO:0014829) | 2.02367137 |
| 187 | peroxisome fission (GO:0016559) | 2.00945321 |
| 188 | cytochrome complex assembly (GO:0017004) | 2.00255554 |
| 189 | mitochondrial transport (GO:0006839) | 1.99334504 |
| 190 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 1.99155607 |
| 191 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 1.99033559 |
| 192 | regulation of cardiac muscle cell contraction (GO:0086004) | 1.98783140 |
| 193 | artery smooth muscle contraction (GO:0014824) | 1.97979410 |
| 194 | ribonucleoprotein complex disassembly (GO:0032988) | 1.96475378 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.14068539 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.34695582 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.26957104 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.52886667 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.45974309 |
| 6 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.44342797 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.10577102 |
| 8 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.93243054 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.90863025 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.80958985 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.78292484 |
| 12 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.43033917 |
| 13 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.34459000 |
| 14 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.19290863 |
| 15 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.17123427 |
| 16 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.06702021 |
| 17 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.99533675 |
| 18 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.99231538 |
| 19 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.96895805 |
| 20 | FUS_26573619_Chip-Seq_HEK293_Human | 1.95504629 |
| 21 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.94505047 |
| 22 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.93602362 |
| 23 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.90771769 |
| 24 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.84972146 |
| 25 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.82220622 |
| 26 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.81837852 |
| 27 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.73170390 |
| 28 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.70121167 |
| 29 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.67689358 |
| 30 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.63929259 |
| 31 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.53874037 |
| 32 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.53452525 |
| 33 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.53363636 |
| 34 | EWS_26573619_Chip-Seq_HEK293_Human | 1.52356187 |
| 35 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.50077337 |
| 36 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.48657914 |
| 37 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.47523560 |
| 38 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.46754784 |
| 39 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.46754784 |
| 40 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.46671353 |
| 41 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.46439377 |
| 42 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.44735954 |
| 43 | P300_19829295_ChIP-Seq_ESCs_Human | 1.43354181 |
| 44 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.42856102 |
| 45 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.41680211 |
| 46 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.38886883 |
| 47 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.37631798 |
| 48 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.37004747 |
| 49 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.36694732 |
| 50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.36142081 |
| 51 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.32718042 |
| 52 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.29810828 |
| 53 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.27960960 |
| 54 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.27470945 |
| 55 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.26221649 |
| 56 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.25459736 |
| 57 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.25064539 |
| 58 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.24071403 |
| 59 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.23940678 |
| 60 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.21690583 |
| 61 | VDR_22108803_ChIP-Seq_LS180_Human | 1.21682683 |
| 62 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.21008514 |
| 63 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.19432683 |
| 64 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.17037469 |
| 65 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.16719905 |
| 66 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.15843278 |
| 67 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.15194801 |
| 68 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.15190825 |
| 69 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.14940291 |
| 70 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.14663300 |
| 71 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.14312804 |
| 72 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.14071333 |
| 73 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.13676168 |
| 74 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.13002380 |
| 75 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.12967482 |
| 76 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.11778564 |
| 77 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.11606112 |
| 78 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.10008038 |
| 79 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.09149283 |
| 80 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.08597637 |
| 81 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.08353714 |
| 82 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.07877166 |
| 83 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.07501927 |
| 84 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.07442549 |
| 85 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.07277695 |
| 86 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.06993870 |
| 87 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.06854062 |
| 88 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.05941940 |
| 89 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.04447785 |
| 90 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.04339048 |
| 91 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.04017515 |
| 92 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03837050 |
| 93 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.03186990 |
| 94 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.02645892 |
| 95 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.02645892 |
| 96 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.02278589 |
| 97 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.02131130 |
| 98 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.01520853 |
| 99 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.01255459 |
| 100 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.00884402 |
| 101 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.00670247 |
| 102 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.00628080 |
| 103 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.00297051 |
| 104 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.00237820 |
| 105 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.00218383 |
| 106 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.99992635 |
| 107 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.99008998 |
| 108 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.98375262 |
| 109 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.98263934 |
| 110 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.97801940 |
| 111 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.96387127 |
| 112 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.95936174 |
| 113 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.95224038 |
| 114 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.95186407 |
| 115 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.95008819 |
| 116 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.94619615 |
| 117 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.94408006 |
| 118 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94174252 |
| 119 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.93668613 |
| 120 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.93539593 |
| 121 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.93532020 |
| 122 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.93258095 |
| 123 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.92844533 |
| 124 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.92490278 |
| 125 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.92264153 |
| 126 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.92004270 |
| 127 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.91961355 |
| 128 | * JUN_21703547_ChIP-Seq_K562_Human | 0.91744603 |
| 129 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.91680004 |
| 130 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.91552356 |
| 131 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.91485534 |
| 132 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.91028854 |
| 133 | * GABP_19822575_ChIP-Seq_HepG2_Human | 0.90873511 |
| 134 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.90790279 |
| 135 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.90756418 |
| 136 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.90285532 |
| 137 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.90249618 |
| 138 | AR_25329375_ChIP-Seq_VCAP_Human | 0.90082701 |
| 139 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.89832970 |
| 140 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.89665516 |
| 141 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.89434231 |
| 142 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.88886281 |
| 143 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.88802555 |
| 144 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.88797968 |
| 145 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.88190705 |
| 146 | CBP_21632823_ChIP-Seq_H3396_Human | 0.88059260 |
| 147 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.87123577 |
| 148 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.87074834 |
| 149 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.85584066 |
| 150 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.85584066 |
| 151 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.85016386 |
| 152 | KDM2B_26808549_Chip-Seq_REH_Human | 0.84430951 |
| 153 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.84330721 |
| 154 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.83278949 |
| 155 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.81890913 |
| 156 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.81014021 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.34597656 |
| 2 | MP0005360_urolithiasis | 6.00518945 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.07173284 |
| 4 | MP0005365_abnormal_bile_salt | 4.84285167 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.15355526 |
| 6 | MP0003195_calcinosis | 3.38386915 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.04482342 |
| 8 | MP0003252_abnormal_bile_duct | 2.96873126 |
| 9 | MP0009780_abnormal_chondrocyte_physiolo | 2.81399435 |
| 10 | MP0005083_abnormal_biliary_tract | 2.78907180 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.67721339 |
| 12 | MP0005332_abnormal_amino_acid | 2.42894206 |
| 13 | MP0000749_muscle_degeneration | 2.41747487 |
| 14 | MP0004270_analgesia | 2.37575959 |
| 15 | MP0000751_myopathy | 2.22820914 |
| 16 | MP0004859_abnormal_synaptic_plasticity | 2.21875713 |
| 17 | MP0001666_abnormal_nutrient_absorption | 2.12603308 |
| 18 | MP0004215_abnormal_myocardial_fiber | 2.12342938 |
| 19 | MP0002876_abnormal_thyroid_physiology | 2.07354208 |
| 20 | MP0009840_abnormal_foam_cell | 1.97428507 |
| 21 | MP0009697_abnormal_copulation | 1.96648432 |
| 22 | MP0004019_abnormal_vitamin_homeostasis | 1.87387815 |
| 23 | MP0002118_abnormal_lipid_homeostasis | 1.79369475 |
| 24 | MP0004145_abnormal_muscle_electrophysio | 1.78321246 |
| 25 | MP0009046_muscle_twitch | 1.78078311 |
| 26 | MP0009379_abnormal_foot_pigmentation | 1.69838795 |
| 27 | MP0005451_abnormal_body_composition | 1.64622067 |
| 28 | MP0003186_abnormal_redox_activity | 1.57007652 |
| 29 | MP0004084_abnormal_cardiac_muscle | 1.53078192 |
| 30 | MP0001764_abnormal_homeostasis | 1.51927108 |
| 31 | MP0002234_abnormal_pharynx_morphology | 1.50608980 |
| 32 | MP0002138_abnormal_hepatobiliary_system | 1.50130665 |
| 33 | MP0006072_abnormal_retinal_apoptosis | 1.47088872 |
| 34 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.45964496 |
| 35 | MP0003191_abnormal_cellular_cholesterol | 1.45157195 |
| 36 | MP0003868_abnormal_feces_composition | 1.44213845 |
| 37 | MP0006276_abnormal_autonomic_nervous | 1.41486733 |
| 38 | MP0003011_delayed_dark_adaptation | 1.41235152 |
| 39 | MP0005330_cardiomyopathy | 1.38716158 |
| 40 | MP0000609_abnormal_liver_physiology | 1.36174052 |
| 41 | MP0003635_abnormal_synaptic_transmissio | 1.36128710 |
| 42 | MP0004036_abnormal_muscle_relaxation | 1.32913806 |
| 43 | MP0001299_abnormal_eye_distance/ | 1.32310559 |
| 44 | MP0010368_abnormal_lymphatic_system | 1.29775489 |
| 45 | MP0003724_increased_susceptibility_to | 1.25102193 |
| 46 | MP0005319_abnormal_enzyme/_coenzyme | 1.24683643 |
| 47 | MP0000013_abnormal_adipose_tissue | 1.23400133 |
| 48 | MP0005423_abnormal_somatic_nervous | 1.23032364 |
| 49 | MP0009764_decreased_sensitivity_to | 1.22461298 |
| 50 | MP0005535_abnormal_body_temperature | 1.22410186 |
| 51 | MP0005646_abnormal_pituitary_gland | 1.21989153 |
| 52 | MP0002269_muscular_atrophy | 1.19222956 |
| 53 | MP0003690_abnormal_glial_cell | 1.18756969 |
| 54 | MP0002736_abnormal_nociception_after | 1.17257348 |
| 55 | MP0002909_abnormal_adrenal_gland | 1.16403891 |
| 56 | MP0002254_reproductive_system_inflammat | 1.16300895 |
| 57 | MP0005408_hypopigmentation | 1.14773205 |
| 58 | MP0002063_abnormal_learning/memory/cond | 1.12720882 |
| 59 | MP0003880_abnormal_central_pattern | 1.11751551 |
| 60 | MP0005187_abnormal_penis_morphology | 1.11383158 |
| 61 | MP0005636_abnormal_mineral_homeostasis | 1.10970928 |
| 62 | MP0005171_absent_coat_pigmentation | 1.09783185 |
| 63 | MP0004043_abnormal_pH_regulation | 1.08537055 |
| 64 | MP0005620_abnormal_muscle_contractility | 1.07554180 |
| 65 | MP0002938_white_spotting | 1.07522335 |
| 66 | MP0009643_abnormal_urine_homeostasis | 1.07442483 |
| 67 | MP0002837_dystrophic_cardiac_calcinosis | 1.07018686 |
| 68 | MP0001984_abnormal_olfaction | 1.06701479 |
| 69 | MP0000747_muscle_weakness | 1.06684315 |
| 70 | MP0002735_abnormal_chemical_nociception | 1.05414224 |
| 71 | MP0004142_abnormal_muscle_tone | 1.05066919 |
| 72 | MP0002972_abnormal_cardiac_muscle | 1.03031876 |
| 73 | MP0001968_abnormal_touch/_nociception | 1.01882070 |
| 74 | MP0008058_abnormal_DNA_repair | 1.01342104 |
| 75 | MP0003137_abnormal_impulse_conducting | 1.00428534 |
| 76 | MP0005084_abnormal_gallbladder_morpholo | 0.98220149 |
| 77 | MP0000778_abnormal_nervous_system | 0.97113779 |
| 78 | MP0000604_amyloidosis | 0.96561037 |
| 79 | MP0005379_endocrine/exocrine_gland_phen | 0.95770680 |
| 80 | MP0006036_abnormal_mitochondrial_physio | 0.95736535 |
| 81 | MP0004885_abnormal_endolymph | 0.95538996 |
| 82 | MP0005647_abnormal_sex_gland | 0.95362927 |
| 83 | MP0008775_abnormal_heart_ventricle | 0.94919578 |
| 84 | MP0003183_abnormal_peptide_metabolism | 0.94715673 |
| 85 | MP0002102_abnormal_ear_morphology | 0.92831620 |
| 86 | MP0001986_abnormal_taste_sensitivity | 0.91988767 |
| 87 | MP0003950_abnormal_plasma_membrane | 0.91932255 |
| 88 | MP0002822_catalepsy | 0.91711570 |
| 89 | MP0005623_abnormal_meninges_morphology | 0.91698027 |
| 90 | MP0004087_abnormal_muscle_fiber | 0.91595991 |
| 91 | MP0002557_abnormal_social/conspecific_i | 0.90244259 |
| 92 | MP0002638_abnormal_pupillary_reflex | 0.90000778 |
| 93 | MP0005248_abnormal_Harderian_gland | 0.89933980 |
| 94 | MP0008789_abnormal_olfactory_epithelium | 0.89689844 |
| 95 | MP0004085_abnormal_heartbeat | 0.89204613 |
| 96 | MP0001542_abnormal_bone_strength | 0.87804649 |
| 97 | MP0005253_abnormal_eye_physiology | 0.87237546 |
| 98 | MP0004924_abnormal_behavior | 0.86389525 |
| 99 | MP0005386_behavior/neurological_phenoty | 0.86389525 |
| 100 | MP0000759_abnormal_skeletal_muscle | 0.86354372 |
| 101 | MP0004381_abnormal_hair_follicle | 0.86190556 |
| 102 | MP0002106_abnormal_muscle_physiology | 0.85965909 |
| 103 | MP0001501_abnormal_sleep_pattern | 0.85565126 |
| 104 | MP0000569_abnormal_digit_pigmentation | 0.84476686 |
| 105 | MP0002090_abnormal_vision | 0.84309745 |
| 106 | MP0004130_abnormal_muscle_cell | 0.82943128 |
| 107 | MP0000920_abnormal_myelination | 0.82718790 |
| 108 | MP0002160_abnormal_reproductive_system | 0.82716611 |
| 109 | MP0001661_extended_life_span | 0.81474279 |
| 110 | MP0006035_abnormal_mitochondrial_morpho | 0.81304498 |
| 111 | MP0005551_abnormal_eye_electrophysiolog | 0.80189567 |
| 112 | MP0001486_abnormal_startle_reflex | 0.80051443 |
| 113 | MP0010030_abnormal_orbit_morphology | 0.79609831 |
| 114 | MP0010386_abnormal_urinary_bladder | 0.79311577 |
| 115 | MP0003633_abnormal_nervous_system | 0.78943363 |
| 116 | MP0005369_muscle_phenotype | 0.78617794 |
| 117 | MP0002078_abnormal_glucose_homeostasis | 0.77918987 |
| 118 | MP0001905_abnormal_dopamine_level | 0.77857030 |
| 119 | MP0001879_abnormal_lymphatic_vessel | 0.77179714 |
| 120 | MP0008932_abnormal_embryonic_tissue | 0.76824757 |
| 121 | MP0002066_abnormal_motor_capabilities/c | 0.75080731 |
| 122 | MP0009763_increased_sensitivity_to | 0.75031768 |
| 123 | MP0002184_abnormal_innervation | 0.74759432 |
| 124 | MP0008872_abnormal_physiological_respon | 0.73607980 |
| 125 | MP0003329_amyloid_beta_deposits | 0.73291603 |
| 126 | MP0005058_abnormal_lysosome_morphology | 0.72970760 |
| 127 | MP0005376_homeostasis/metabolism_phenot | 0.72827887 |
| 128 | MP0005645_abnormal_hypothalamus_physiol | 0.72363826 |
| 129 | MP0002733_abnormal_thermal_nociception | 0.71813464 |
| 130 | MP0008469_abnormal_protein_level | 0.71704953 |
| 131 | MP0005334_abnormal_fat_pad | 0.71444304 |
| 132 | MP0000230_abnormal_systemic_arterial | 0.71159588 |
| 133 | MP0005670_abnormal_white_adipose | 0.71016564 |
| 134 | MP0010234_abnormal_vibrissa_follicle | 0.70272607 |
| 135 | MP0002064_seizures | 0.70200331 |
| 136 | MP0001529_abnormal_vocalization | 0.70133544 |
| 137 | MP0001440_abnormal_grooming_behavior | 0.69939836 |
| 138 | MP0004484_altered_response_of | 0.69924074 |
| 139 | MP0009765_abnormal_xenobiotic_induced | 0.69176462 |
| 140 | MP0004782_abnormal_surfactant_physiolog | 0.69025735 |
| 141 | MP0004272_abnormal_basement_membrane | 0.68666689 |
| 142 | MP0002877_abnormal_melanocyte_morpholog | 0.68593738 |
| 143 | MP0009642_abnormal_blood_homeostasis | 0.68591211 |
| 144 | MP0000955_abnormal_spinal_cord | 0.68313433 |
| 145 | MP0003656_abnormal_erythrocyte_physiolo | 0.68079766 |
| 146 | MP0009745_abnormal_behavioral_response | 0.66205586 |
| 147 | MP0002272_abnormal_nervous_system | 0.65693334 |
| 148 | MP0002067_abnormal_sensory_capabilities | 0.62631690 |
| 149 | MP0002734_abnormal_mechanical_nocicepti | 0.62569012 |
| 150 | MP0004742_abnormal_vestibular_system | 0.61906997 |
| 151 | MP0008004_abnormal_stomach_pH | 0.60386468 |
| 152 | MP0000639_abnormal_adrenal_gland | 0.59394925 |
| 153 | MP0005448_abnormal_energy_balance | 0.58495224 |
| 154 | MP0001756_abnormal_urination | 0.58474873 |
| 155 | MP0000538_abnormal_urinary_bladder | 0.57322710 |
| 156 | MP0002295_abnormal_pulmonary_circulatio | 0.57284499 |
| 157 | MP0002572_abnormal_emotion/affect_behav | 0.57248245 |
| 158 | MP0006082_CNS_inflammation | 0.54514503 |
| 159 | MP0008874_decreased_physiological_sensi | 0.54138005 |
| 160 | MP0002971_abnormal_brown_adipose | 0.53357603 |
| 161 | MP0004147_increased_porphyrin_level | 0.53071511 |
| 162 | MP0001970_abnormal_pain_threshold | 0.52823981 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.23884192 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 5.40094598 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 5.06371175 |
| 4 | Xanthomatosis (HP:0000991) | 4.75526581 |
| 5 | Deep venous thrombosis (HP:0002625) | 4.49660348 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 4.46938823 |
| 7 | Hyperlipoproteinemia (HP:0010980) | 4.27191463 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.15996184 |
| 9 | Conjugated hyperbilirubinemia (HP:0002908) | 3.86860638 |
| 10 | Joint hemorrhage (HP:0005261) | 3.80937250 |
| 11 | Complement deficiency (HP:0004431) | 3.57715837 |
| 12 | Cerebral edema (HP:0002181) | 3.52942915 |
| 13 | Acute encephalopathy (HP:0006846) | 3.47747876 |
| 14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.45480127 |
| 15 | Epidermoid cyst (HP:0200040) | 3.42532459 |
| 16 | Ketosis (HP:0001946) | 3.40912930 |
| 17 | Hypolipoproteinemia (HP:0010981) | 3.33549532 |
| 18 | Hypoglycemic coma (HP:0001325) | 3.33089606 |
| 19 | Hyperglycinemia (HP:0002154) | 3.29583236 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.23119517 |
| 21 | Nemaline bodies (HP:0003798) | 3.18516465 |
| 22 | Fat malabsorption (HP:0002630) | 3.16135466 |
| 23 | Acute necrotizing encephalopathy (HP:0006965) | 3.12959599 |
| 24 | Abnormality of glycine metabolism (HP:0010895) | 3.12534986 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.12534986 |
| 26 | Hyperammonemia (HP:0001987) | 3.11006419 |
| 27 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.10647762 |
| 28 | Hyperglycinuria (HP:0003108) | 3.09559589 |
| 29 | Increased hepatocellular lipid droplets (HP:0006565) | 3.08468404 |
| 30 | Hepatic necrosis (HP:0002605) | 3.04351061 |
| 31 | Abnormality of the common coagulation pathway (HP:0010990) | 3.02470974 |
| 32 | Muscle fiber inclusion bodies (HP:0100299) | 2.92886896 |
| 33 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.90650223 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.90045658 |
| 35 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.89388224 |
| 36 | Exercise-induced muscle cramps (HP:0003710) | 2.87419576 |
| 37 | Hypoalphalipoproteinemia (HP:0003233) | 2.85982320 |
| 38 | Abnormality of the intrinsic pathway (HP:0010989) | 2.85277283 |
| 39 | Generalized aminoaciduria (HP:0002909) | 2.84441668 |
| 40 | Abnormality of methionine metabolism (HP:0010901) | 2.81245281 |
| 41 | Focal motor seizures (HP:0011153) | 2.79158597 |
| 42 | Lethargy (HP:0001254) | 2.75881778 |
| 43 | Mitochondrial inheritance (HP:0001427) | 2.71887666 |
| 44 | Progressive macrocephaly (HP:0004481) | 2.69866608 |
| 45 | Ketoacidosis (HP:0001993) | 2.67811497 |
| 46 | Myokymia (HP:0002411) | 2.66095419 |
| 47 | Hepatocellular necrosis (HP:0001404) | 2.64989865 |
| 48 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.64940822 |
| 49 | Bundle branch block (HP:0011710) | 2.57541863 |
| 50 | Parakeratosis (HP:0001036) | 2.53384579 |
| 51 | Abnormality of urine glucose concentration (HP:0011016) | 2.53283132 |
| 52 | Glycosuria (HP:0003076) | 2.53283132 |
| 53 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.51600251 |
| 54 | Metabolic acidosis (HP:0001942) | 2.51411077 |
| 55 | Hypercholesterolemia (HP:0003124) | 2.50867851 |
| 56 | Calf muscle hypertrophy (HP:0008981) | 2.50711104 |
| 57 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.48298653 |
| 58 | Dicarboxylic aciduria (HP:0003215) | 2.48298653 |
| 59 | Neuroendocrine neoplasm (HP:0100634) | 2.44451843 |
| 60 | Increased serum pyruvate (HP:0003542) | 2.44143283 |
| 61 | Abnormality of glycolysis (HP:0004366) | 2.44143283 |
| 62 | Hyperbilirubinemia (HP:0002904) | 2.43115174 |
| 63 | Abnormality of complement system (HP:0005339) | 2.42716196 |
| 64 | Steatorrhea (HP:0002570) | 2.42206287 |
| 65 | Action tremor (HP:0002345) | 2.42132473 |
| 66 | Vomiting (HP:0002013) | 2.39964433 |
| 67 | Hyperventilation (HP:0002883) | 2.38127617 |
| 68 | Atonic seizures (HP:0010819) | 2.38001320 |
| 69 | Abnormality of the calf musculature (HP:0001430) | 2.37872815 |
| 70 | Systemic lupus erythematosus (HP:0002725) | 2.36930571 |
| 71 | Abnormality of serum amino acid levels (HP:0003112) | 2.36637976 |
| 72 | Delayed CNS myelination (HP:0002188) | 2.34497743 |
| 73 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.34120535 |
| 74 | Exercise intolerance (HP:0003546) | 2.31793494 |
| 75 | Increased CSF lactate (HP:0002490) | 2.30626471 |
| 76 | Respiratory failure (HP:0002878) | 2.29032263 |
| 77 | Hypoglycemic seizures (HP:0002173) | 2.27282881 |
| 78 | Leukodystrophy (HP:0002415) | 2.27081234 |
| 79 | Renal cortical cysts (HP:0000803) | 2.25243704 |
| 80 | Renal Fanconi syndrome (HP:0001994) | 2.25142969 |
| 81 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.24504929 |
| 82 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.24504929 |
| 83 | Proximal tubulopathy (HP:0000114) | 2.21467981 |
| 84 | Hypothermia (HP:0002045) | 2.20632325 |
| 85 | Nausea (HP:0002018) | 2.18415776 |
| 86 | * Abnormality of purine metabolism (HP:0004352) | 2.17252664 |
| 87 | Sudden death (HP:0001699) | 2.14896173 |
| 88 | Hypophosphatemic rickets (HP:0004912) | 2.11755471 |
| 89 | Palpitations (HP:0001962) | 2.10252787 |
| 90 | Fair hair (HP:0002286) | 2.10235559 |
| 91 | Increased intramyocellular lipid droplets (HP:0012240) | 2.07493198 |
| 92 | Myoglobinuria (HP:0002913) | 2.06849363 |
| 93 | Skin nodule (HP:0200036) | 2.04630497 |
| 94 | Abnormal gallbladder morphology (HP:0012437) | 2.02936254 |
| 95 | * Abnormality of nucleobase metabolism (HP:0010932) | 2.02822614 |
| 96 | Lactic acidosis (HP:0003128) | 2.00192911 |
| 97 | Symptomatic seizures (HP:0011145) | 1.99924371 |
| 98 | Cholecystitis (HP:0001082) | 1.99639721 |
| 99 | Abnormal gallbladder physiology (HP:0012438) | 1.99639721 |
| 100 | Pancreatitis (HP:0001733) | 1.99295086 |
| 101 | Rimmed vacuoles (HP:0003805) | 1.98625282 |
| 102 | Abnormality of proline metabolism (HP:0010907) | 1.97682420 |
| 103 | Hydroxyprolinuria (HP:0003080) | 1.97682420 |
| 104 | Absence seizures (HP:0002121) | 1.96498944 |
| 105 | Methylmalonic acidemia (HP:0002912) | 1.96317109 |
| 106 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.95234757 |
| 107 | Lipid accumulation in hepatocytes (HP:0006561) | 1.95171366 |
| 108 | Alkalosis (HP:0001948) | 1.94889193 |
| 109 | Vascular calcification (HP:0004934) | 1.94776329 |
| 110 | Type 1 muscle fiber predominance (HP:0003803) | 1.94273116 |
| 111 | Hyperphosphaturia (HP:0003109) | 1.93623324 |
| 112 | Myotonia (HP:0002486) | 1.93216762 |
| 113 | Hemiparesis (HP:0001269) | 1.92704408 |
| 114 | Cerebral hypomyelination (HP:0006808) | 1.92188051 |
| 115 | X-linked dominant inheritance (HP:0001423) | 1.91416158 |
| 116 | 3-Methylglutaconic aciduria (HP:0003535) | 1.91280044 |
| 117 | Amniotic constriction ring (HP:0009775) | 1.91179916 |
| 118 | Abnormality of placental membranes (HP:0011409) | 1.91179916 |
| 119 | Sensorimotor neuropathy (HP:0007141) | 1.89817071 |
| 120 | Myocardial infarction (HP:0001658) | 1.89428264 |
| 121 | Spontaneous abortion (HP:0005268) | 1.89042132 |
| 122 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.88892932 |
| 123 | Increased serum lactate (HP:0002151) | 1.88103328 |
| 124 | Fetal akinesia sequence (HP:0001989) | 1.87612154 |
| 125 | Hypokinesia (HP:0002375) | 1.87212883 |
| 126 | Pheochromocytoma (HP:0002666) | 1.86750180 |
| 127 | Reduced antithrombin III activity (HP:0001976) | 1.86533744 |
| 128 | Abnormality of renal resorption (HP:0011038) | 1.85696308 |
| 129 | Amyloidosis (HP:0011034) | 1.85134182 |
| 130 | Irritability (HP:0000737) | 1.84916884 |
| 131 | EMG: myopathic abnormalities (HP:0003458) | 1.84912651 |
| 132 | Postural tremor (HP:0002174) | 1.84837608 |
| 133 | Enlarged kidneys (HP:0000105) | 1.83390883 |
| 134 | Optic disc pallor (HP:0000543) | 1.82351033 |
| 135 | Generalized tonic-clonic seizures (HP:0002069) | 1.82003188 |
| 136 | Type I transferrin isoform profile (HP:0003642) | 1.81051788 |
| 137 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.80981751 |
| 138 | CNS demyelination (HP:0007305) | 1.80973481 |
| 139 | Increased muscle lipid content (HP:0009058) | 1.79935305 |
| 140 | Gait imbalance (HP:0002141) | 1.79260038 |
| 141 | Methylmalonic aciduria (HP:0012120) | 1.78624787 |
| 142 | Cholelithiasis (HP:0001081) | 1.78316633 |
| 143 | Rickets (HP:0002748) | 1.78144187 |
| 144 | Gout (HP:0001997) | 1.76654931 |
| 145 | Medial flaring of the eyebrow (HP:0010747) | 1.76228578 |
| 146 | Rhabdomyolysis (HP:0003201) | 1.75297130 |
| 147 | Anxiety (HP:0000739) | 1.73343809 |
| 148 | Left ventricular hypertrophy (HP:0001712) | 1.70361266 |
| 149 | Abnormality of the anterior horn cell (HP:0006802) | 1.69464839 |
| 150 | Degeneration of anterior horn cells (HP:0002398) | 1.69464839 |
| 151 | Delayed gross motor development (HP:0002194) | 1.69431733 |
| 152 | Hyporeflexia of lower limbs (HP:0002600) | 1.68948894 |
| 153 | Microglossia (HP:0000171) | 1.68906151 |
| 154 | Dialeptic seizures (HP:0011146) | 1.67674807 |
| 155 | Congenital primary aphakia (HP:0007707) | 1.64869917 |
| 156 | Diminished movement (HP:0002374) | 1.64638498 |
| 157 | Testicular atrophy (HP:0000029) | 1.60946060 |
| 158 | Limb-girdle muscle atrophy (HP:0003797) | 1.59999464 |
| 159 | Limb dystonia (HP:0002451) | 1.59607194 |
| 160 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.59457771 |
| 161 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.59457771 |
| 162 | Heart block (HP:0012722) | 1.58853808 |
| 163 | Poor suck (HP:0002033) | 1.58338822 |
| 164 | Neck muscle weakness (HP:0000467) | 1.58116075 |
| 165 | Neoplasm of the adrenal gland (HP:0100631) | 1.57998820 |
| 166 | Congenital malformation of the right heart (HP:0011723) | 1.57738485 |
| 167 | Double outlet right ventricle (HP:0001719) | 1.57738485 |
| 168 | Febrile seizures (HP:0002373) | 1.57228329 |
| 169 | Shoulder girdle muscle weakness (HP:0003547) | 1.56005319 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 3.62786902 |
| 2 | MAP3K12 | 3.54673476 |
| 3 | BCKDK | 2.92349521 |
| 4 | INSRR | 2.49260429 |
| 5 | PBK | 2.44827091 |
| 6 | PNCK | 2.36433565 |
| 7 | BCR | 2.24921203 |
| 8 | FRK | 2.21559026 |
| 9 | MST1R | 2.14016266 |
| 10 | TNIK | 2.11849520 |
| 11 | NEK1 | 2.08177568 |
| 12 | MAP2K4 | 2.06633281 |
| 13 | OXSR1 | 2.05506765 |
| 14 | TSSK6 | 2.03901566 |
| 15 | EIF2AK1 | 1.94004781 |
| 16 | EIF2AK3 | 1.91582240 |
| 17 | STK39 | 1.89422373 |
| 18 | VRK2 | 1.85421893 |
| 19 | TESK1 | 1.81681669 |
| 20 | PIK3CG | 1.80175476 |
| 21 | ERBB4 | 1.76765259 |
| 22 | BMPR1B | 1.62392579 |
| 23 | STK16 | 1.61530257 |
| 24 | MAP2K7 | 1.59420996 |
| 25 | MARK1 | 1.59276294 |
| 26 | MAP3K14 | 1.54405589 |
| 27 | CCNB1 | 1.53541055 |
| 28 | SCYL2 | 1.52962034 |
| 29 | BUB1 | 1.52626948 |
| 30 | IRAK3 | 1.46635001 |
| 31 | ERBB3 | 1.45033222 |
| 32 | SIK1 | 1.39400879 |
| 33 | BRSK1 | 1.37144691 |
| 34 | GRK5 | 1.36747352 |
| 35 | BMPR2 | 1.36463199 |
| 36 | CSNK1G2 | 1.35084951 |
| 37 | PLK3 | 1.34483026 |
| 38 | WEE1 | 1.33466544 |
| 39 | WNK4 | 1.29518016 |
| 40 | PAK3 | 1.28378062 |
| 41 | SRPK1 | 1.27461207 |
| 42 | TAOK3 | 1.27145664 |
| 43 | CSNK1G3 | 1.27002572 |
| 44 | ADRBK2 | 1.22701350 |
| 45 | BRSK2 | 1.21824396 |
| 46 | MYLK | 1.21475951 |
| 47 | STK38L | 1.20241640 |
| 48 | DAPK2 | 1.18846864 |
| 49 | IRAK2 | 1.16456784 |
| 50 | GRK7 | 1.16059001 |
| 51 | PAK6 | 1.15455652 |
| 52 | ARAF | 1.13828344 |
| 53 | MOS | 1.13327101 |
| 54 | MST4 | 1.12208099 |
| 55 | CSNK1G1 | 1.11397465 |
| 56 | CSNK1A1L | 1.09353111 |
| 57 | EPHA4 | 1.09143036 |
| 58 | ABL2 | 1.06545356 |
| 59 | NME1 | 1.06466732 |
| 60 | MUSK | 1.05498586 |
| 61 | PDK2 | 1.05428000 |
| 62 | IRAK1 | 1.05334455 |
| 63 | PIK3CA | 1.05211440 |
| 64 | MINK1 | 1.04087077 |
| 65 | SIK3 | 1.03532469 |
| 66 | NTRK3 | 1.02975573 |
| 67 | FGFR4 | 1.00847703 |
| 68 | PRPF4B | 0.98876003 |
| 69 | MAP3K9 | 0.96918375 |
| 70 | MAP3K4 | 0.96849071 |
| 71 | SGK494 | 0.96520102 |
| 72 | SGK223 | 0.96520102 |
| 73 | PRKCE | 0.94148716 |
| 74 | PINK1 | 0.92698136 |
| 75 | CAMK2G | 0.92246693 |
| 76 | DMPK | 0.88797611 |
| 77 | TTK | 0.88550438 |
| 78 | MAP3K13 | 0.88512868 |
| 79 | UHMK1 | 0.87455179 |
| 80 | CAMKK2 | 0.86004446 |
| 81 | MAP4K2 | 0.83033841 |
| 82 | PLK2 | 0.82379590 |
| 83 | NEK9 | 0.82212554 |
| 84 | ERN1 | 0.82064822 |
| 85 | MET | 0.81818956 |
| 86 | PKN1 | 0.81772344 |
| 87 | NEK6 | 0.81453085 |
| 88 | MAP3K11 | 0.80594423 |
| 89 | PRKCG | 0.80592748 |
| 90 | WNK3 | 0.80530889 |
| 91 | VRK1 | 0.78508953 |
| 92 | CAMK2A | 0.78471657 |
| 93 | MAPKAPK5 | 0.77967849 |
| 94 | PRKD3 | 0.77691223 |
| 95 | MAP3K2 | 0.75418163 |
| 96 | GRK1 | 0.74233032 |
| 97 | MAPK15 | 0.74137874 |
| 98 | FGR | 0.73522955 |
| 99 | PLK1 | 0.73267375 |
| 100 | AKT3 | 0.72801299 |
| 101 | NTRK2 | 0.71838347 |
| 102 | CDK8 | 0.71288122 |
| 103 | ROCK2 | 0.70943651 |
| 104 | ADRBK1 | 0.70819450 |
| 105 | TRIM28 | 0.70717039 |
| 106 | ILK | 0.69973594 |
| 107 | LATS2 | 0.69715005 |
| 108 | RIPK4 | 0.68231795 |
| 109 | DAPK1 | 0.65616425 |
| 110 | PRKCQ | 0.65134997 |
| 111 | CAMK2B | 0.65018675 |
| 112 | MAP2K1 | 0.64448944 |
| 113 | SGK2 | 0.60834779 |
| 114 | CAMK2D | 0.58807394 |
| 115 | CDK14 | 0.57751994 |
| 116 | MAPK12 | 0.57692479 |
| 117 | IRAK4 | 0.57411098 |
| 118 | MAPK4 | 0.56080782 |
| 119 | EPHB2 | 0.55564769 |
| 120 | CDK18 | 0.55506040 |
| 121 | MAPK13 | 0.55479020 |
| 122 | PAK4 | 0.54453335 |
| 123 | PRKACA | 0.53989674 |
| 124 | MAP2K6 | 0.53257710 |
| 125 | TYK2 | 0.52020433 |
| 126 | BRAF | 0.51686756 |
| 127 | CDK15 | 0.51609702 |
| 128 | FER | 0.51410632 |
| 129 | IKBKE | 0.50485349 |
| 130 | NUAK1 | 0.50015476 |
| 131 | PRKAA2 | 0.49759413 |
| 132 | CDK11A | 0.49224390 |
| 133 | PRKCZ | 0.48697278 |
| 134 | PRKACG | 0.48421186 |
| 135 | JAK1 | 0.48098864 |
| 136 | YES1 | 0.48025187 |
| 137 | PRKCA | 0.47395296 |
| 138 | ROCK1 | 0.46352023 |
| 139 | AKT2 | 0.45760628 |
| 140 | TIE1 | 0.45290541 |
| 141 | PRKG1 | 0.45113991 |
| 142 | CDK3 | 0.44499978 |
| 143 | LIMK1 | 0.44113734 |
| 144 | CDC7 | 0.43199423 |
| 145 | PLK4 | 0.43089251 |
| 146 | IGF1R | 0.42375302 |
| 147 | PHKG2 | 0.42314446 |
| 148 | PHKG1 | 0.42314446 |
| 149 | EIF2AK2 | 0.42249414 |
| 150 | OBSCN | 0.42153525 |
| 151 | LMTK2 | 0.41952404 |
| 152 | TEC | 0.41910146 |
| 153 | JAK2 | 0.41607707 |
| 154 | TBK1 | 0.41485917 |
| 155 | NTRK1 | 0.41451255 |
| 156 | CDK19 | 0.41262353 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.64154929 |
| 2 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.89688968 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.67440722 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 2.58598327 |
| 5 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.44013971 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.33606687 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.33124689 |
| 8 | Histidine metabolism_Homo sapiens_hsa00340 | 2.30764234 |
| 9 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.29546911 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.29047859 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.25642255 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.25325327 |
| 13 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.23893082 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 2.19345661 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.18551474 |
| 16 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.17222629 |
| 17 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.12068043 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.10418200 |
| 19 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.09898303 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.08682889 |
| 21 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.06129000 |
| 22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.05777771 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.95850490 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.93641017 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.93597918 |
| 26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.90490799 |
| 27 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.89309767 |
| 28 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.87038791 |
| 29 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.78686032 |
| 30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.77615129 |
| 31 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.76868835 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.76555721 |
| 33 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.75548227 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.73651172 |
| 35 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.60351778 |
| 36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.59965072 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.53579676 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.48079872 |
| 39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.38775047 |
| 40 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.35642407 |
| 41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.25769352 |
| 42 | RNA polymerase_Homo sapiens_hsa03020 | 1.23218996 |
| 43 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.19538454 |
| 44 | Parkinsons disease_Homo sapiens_hsa05012 | 1.15987892 |
| 45 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.13671172 |
| 46 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.09042978 |
| 47 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.05361144 |
| 48 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.04399201 |
| 49 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.04398750 |
| 50 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.03847077 |
| 51 | * Folate biosynthesis_Homo sapiens_hsa00790 | 1.03502161 |
| 52 | Bile secretion_Homo sapiens_hsa04976 | 1.03212213 |
| 53 | Alzheimers disease_Homo sapiens_hsa05010 | 1.00714477 |
| 54 | Mismatch repair_Homo sapiens_hsa03430 | 1.00005289 |
| 55 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.99747248 |
| 56 | Ribosome_Homo sapiens_hsa03010 | 0.96679671 |
| 57 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.95749461 |
| 58 | Insulin secretion_Homo sapiens_hsa04911 | 0.93784746 |
| 59 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.93323306 |
| 60 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.93275154 |
| 61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.91923125 |
| 62 | Circadian rhythm_Homo sapiens_hsa04710 | 0.91490073 |
| 63 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.90308695 |
| 64 | ABC transporters_Homo sapiens_hsa02010 | 0.89270019 |
| 65 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.88962549 |
| 66 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.88312647 |
| 67 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.87790282 |
| 68 | Carbon metabolism_Homo sapiens_hsa01200 | 0.87652464 |
| 69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.83741533 |
| 70 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.80702980 |
| 71 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.79249551 |
| 72 | Circadian entrainment_Homo sapiens_hsa04713 | 0.77794783 |
| 73 | Protein export_Homo sapiens_hsa03060 | 0.77682258 |
| 74 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.77174461 |
| 75 | RNA degradation_Homo sapiens_hsa03018 | 0.76818211 |
| 76 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.76123429 |
| 77 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.75409834 |
| 78 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.74815429 |
| 79 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.74790351 |
| 80 | Basal transcription factors_Homo sapiens_hsa03022 | 0.73092420 |
| 81 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.72307385 |
| 82 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.72078428 |
| 83 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.72016715 |
| 84 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.70963212 |
| 85 | Purine metabolism_Homo sapiens_hsa00230 | 0.70702511 |
| 86 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.69162158 |
| 87 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.67497178 |
| 88 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64846651 |
| 89 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.64425310 |
| 90 | Homologous recombination_Homo sapiens_hsa03440 | 0.64235027 |
| 91 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.62645725 |
| 92 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.62273454 |
| 93 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.61662115 |
| 94 | Morphine addiction_Homo sapiens_hsa05032 | 0.58691171 |
| 95 | Huntingtons disease_Homo sapiens_hsa05016 | 0.57718039 |
| 96 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.57504211 |
| 97 | DNA replication_Homo sapiens_hsa03030 | 0.54992702 |
| 98 | Cocaine addiction_Homo sapiens_hsa05030 | 0.53919829 |
| 99 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.53416715 |
| 100 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.50179102 |
| 101 | Salivary secretion_Homo sapiens_hsa04970 | 0.48905187 |
| 102 | RNA transport_Homo sapiens_hsa03013 | 0.47856799 |
| 103 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.47413743 |
| 104 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.47218341 |
| 105 | Long-term potentiation_Homo sapiens_hsa04720 | 0.46803043 |
| 106 | Renin secretion_Homo sapiens_hsa04924 | 0.46705425 |
| 107 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.45527783 |
| 108 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.42888705 |
| 109 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.42643783 |
| 110 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.42078474 |
| 111 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.40852084 |
| 112 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.38591291 |
| 113 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.36265014 |
| 114 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.35716499 |
| 115 | * Sulfur relay system_Homo sapiens_hsa04122 | 0.34100166 |
| 116 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.32099802 |
| 117 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.32032445 |
| 118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.31618131 |
| 119 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.31602128 |
| 120 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.29859534 |
| 121 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.29622224 |
| 122 | Prion diseases_Homo sapiens_hsa05020 | 0.29193853 |
| 123 | Lysine degradation_Homo sapiens_hsa00310 | 0.24210943 |
| 124 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.21242330 |
| 125 | Galactose metabolism_Homo sapiens_hsa00052 | 0.20848223 |
| 126 | Phagosome_Homo sapiens_hsa04145 | 0.19469216 |
| 127 | Nicotine addiction_Homo sapiens_hsa05033 | 0.18717859 |
| 128 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.17232513 |
| 129 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15091918 |
| 130 | GABAergic synapse_Homo sapiens_hsa04727 | 0.14194451 |
| 131 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.12700587 |
| 132 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.12101014 |
| 133 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.12091282 |
| 134 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.10841211 |
| 135 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.10556821 |
| 136 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.10136253 |
| 137 | Mineral absorption_Homo sapiens_hsa04978 | 0.09534639 |
| 138 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.07618513 |
| 139 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.06993833 |

